Dentsply Sirona (XRAY)

• Market cap: $3.73B
• 1 day: -1.06%
• 5 days: 0.11%
• 1 month: -1.11%
• 3 months: 0.59%
• 6 months: -23.75%
• Year to date: 0.00%
• 1 year: -43.32%
• 5 years: -67.02%
• 10 years: -63.94%
• Sector: Healthcare
• Industry: Dental Equipment & Supplies

About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Employees: 15,000

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

61% more call options, than puts

Call options by funds: $19.9M | Put options by funds: $12.3M

0% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]

1% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 122

1.95% less ownership

Funds ownership: 102.72% [Q3] → 100.77% (-1.95%) [Q4]

8% less funds holding

Funds holding: 378 [Q3] → 348 (-30) [Q4]

20% less first-time investments, than exits

New positions opened: 72 | Existing positions closed: 90

32% less capital invested

Capital invested by funds: $5.63B [Q3] → $3.8B (-$1.82B) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $20 7% upside
• Avg. target: $22 19% upside
• High target: $27 44% upside

7 analyst ratings

• positive: 3 43%
• neutral: 4 57%
• negative: 0 0%

Wells Fargo Vik Chopra 83% 1-year accuracy 10 / 12 met price target	7% upside $20	Equal-Weight Initiated	14 Feb 2025
Needham David Saxon 37% 1-year accuracy 24 / 65 met price target	33% upside $25	Buy Reiterated	11 Feb 2025
Jefferies Glen Santangelo 60% 1-year accuracy 6 / 10 met price target	7% upside $20	Hold Downgraded	23 Jan 2025
Evercore ISI Group Elizabeth Anderson 51% 1-year accuracy 18 / 35 met price target	7% upside $20	In-Line Downgraded	7 Jan 2025
Morgan Stanley Erin Wright 50% 1-year accuracy 14 / 28 met price target	23% upside $23	Overweight Maintained	17 Dec 2024